Cargando…
Quantifying Tip60 (Kat5) stratifies breast cancer
Breast cancer is stratified into four distinct clinical subtypes, using three key biomarkers (Her2/Neu gene status, Estrogen and Progesterone receptor status). However, each subtype is a heterogeneous group, displaying significant variation in survival rates and treatment response. New biomarkers ar...
Autores principales: | McGuire, A., Casey, M. C., Shalaby, A., Kalinina, O., Curran, C., Webber, M., Callagy, G., Holian, E., Bourke, E., Kerin, M. J., Brown, J. A. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405843/ https://www.ncbi.nlm.nih.gov/pubmed/30846725 http://dx.doi.org/10.1038/s41598-019-40221-5 |
Ejemplares similares
-
Quantifying Argonaute 2 (Ago2) expression to stratify breast cancer
por: Casey, M.C., et al.
Publicado: (2019) -
TIP60/KAT5 is required for neuronal viability in hippocampal CA1
por: Urban, Inga, et al.
Publicado: (2019) -
Targeting cancer using KAT inhibitors to mimic lethal knockouts
por: Brown, James A.L., et al.
Publicado: (2016) -
Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with Trastuzumab
por: McGuire, Andrew, et al.
Publicado: (2017) -
Tip60/KAT5 Histone Acetyltransferase Is Required for Maintenance and Neurogenesis of Embryonic Neural Stem Cells
por: Tominaga, Kaoru, et al.
Publicado: (2023)